-
Je něco špatně v tomto záznamu ?
A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis
EAE. Elhassan, T. Kmochová, KA. Benson, NK. Fennelly, V. Barešová, K. Kidd, B. Doyle, A. Dorman, MM. Morrin, NC. Kyne, P. Vyleťal, H. Hartmannová, K. Hodaňová, J. Sovová, D. Mušálková, A. Vrbacká, A. Přistoupilová, J. Živný, K. Svojšová, M....
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2016
PubMed Central
od 2016
Europe PubMed Central
od 2016
ROAD: Directory of Open Access Scholarly Resources
od 2016
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Monoallelic variants in the ALG5 gene encoding asparagine-linked glycosylation protein 5 homolog (ALG5) have been recently shown to disrupt polycystin-1 (PC1) maturation and trafficking via underglycosylation, causing an autosomal dominant polycystic kidney disease-like (ADPKD-like) phenotype and interstitial fibrosis. In this report, we present clinical, genetic, histopathologic, and protein structure and functional correlates of a new ALG5 variant, p.R79W, that we identified in 2 distant genetically related Irish families displaying an atypical late-onset ADPKD phenotype combined with tubulointerstitial damage. METHODS: Whole exome and targeted sequencing were used for segregation analysis of available relatives. This was followed by immunohistochemistry examinations of kidney biopsies, and targeted (UMOD, MUC1) and untargeted plasma proteome and N-glycomic studies. RESULTS: We identified a monoallelic ALG5 variant [GRCh37 (NM_013338.5): g.37569565G>A, c.235C>T; p.R79W] that cosegregates in 23 individuals, of whom 18 were clinically affected. We detected abnormal localization of ALG5 in the Golgi apparatus of renal tubular cells in patients' kidney specimens. Further, we detected the pathological accumulation of uromodulin, an N-glycosylated glycosylphosphatidylinositol (GPI)-anchored protein, in the endoplasmic reticulum (ER), but not mucin-1, an O- and N-glycosylated protein. Biochemical investigation revealed decreased plasma and urinary uromodulin levels in clinically affected individuals. Proteomic and glycoproteomic profiling revealed the dysregulation of chronic kidney disease (CKD)-associated proteins. CONCLUSION: ALG5 dysfunction adversely affects maturation and trafficking of N-glycosylated and GPI anchored protein uromodulin, leading to structural and functional changes in the kidney. Our findings confirm ALG5 as a cause of late-onset ADPKD and provide additional insight into the molecular mechanisms of ADPKD-ALG5.
Department of Medicine Royal College of Surgeons in Ireland Dublin Ireland
Department of Nephrology and Transplantation Beaumont Hospital Dublin Ireland
Department of Pathology Beaumont Hospital Dublin Ireland
Department of Radiology Beaumont Hospital and Royal College of Surgeons in Ireland Dublin Ireland
Institute of Microbiology The Czech Academy of Sciences Vestec Czech Republic
School of Pharmacy and Biomolecular Sciences Royal College of Surgeons Dublin Ireland
Section on Nephrology Wake Forest School of Medicine Winston Salem North Carolina USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018300
- 003
- CZ-PrNML
- 005
- 20241016082029.0
- 007
- ta
- 008
- 241008s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ekir.2024.04.031 $2 doi
- 035 __
- $a (PubMed)39081747
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Elhassan, Elhussein A E $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland $u Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
- 245 12
- $a A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis / $c EAE. Elhassan, T. Kmochová, KA. Benson, NK. Fennelly, V. Barešová, K. Kidd, B. Doyle, A. Dorman, MM. Morrin, NC. Kyne, P. Vyleťal, H. Hartmannová, K. Hodaňová, J. Sovová, D. Mušálková, A. Vrbacká, A. Přistoupilová, J. Živný, K. Svojšová, M. Radina, V. Stránecký, D. Loginov, P. Pompach, P. Novák, Z. Vaníčková, H. Hansíková, S. Rajnochová-Bloudíčková, O. Viklický, H. Hůlková, GL. Cavalleri, A. Hnízda, AJ. Bleyer, S. Kmoch, PJ. Conlon, M. Živná
- 520 9_
- $a INTRODUCTION: Monoallelic variants in the ALG5 gene encoding asparagine-linked glycosylation protein 5 homolog (ALG5) have been recently shown to disrupt polycystin-1 (PC1) maturation and trafficking via underglycosylation, causing an autosomal dominant polycystic kidney disease-like (ADPKD-like) phenotype and interstitial fibrosis. In this report, we present clinical, genetic, histopathologic, and protein structure and functional correlates of a new ALG5 variant, p.R79W, that we identified in 2 distant genetically related Irish families displaying an atypical late-onset ADPKD phenotype combined with tubulointerstitial damage. METHODS: Whole exome and targeted sequencing were used for segregation analysis of available relatives. This was followed by immunohistochemistry examinations of kidney biopsies, and targeted (UMOD, MUC1) and untargeted plasma proteome and N-glycomic studies. RESULTS: We identified a monoallelic ALG5 variant [GRCh37 (NM_013338.5): g.37569565G>A, c.235C>T; p.R79W] that cosegregates in 23 individuals, of whom 18 were clinically affected. We detected abnormal localization of ALG5 in the Golgi apparatus of renal tubular cells in patients' kidney specimens. Further, we detected the pathological accumulation of uromodulin, an N-glycosylated glycosylphosphatidylinositol (GPI)-anchored protein, in the endoplasmic reticulum (ER), but not mucin-1, an O- and N-glycosylated protein. Biochemical investigation revealed decreased plasma and urinary uromodulin levels in clinically affected individuals. Proteomic and glycoproteomic profiling revealed the dysregulation of chronic kidney disease (CKD)-associated proteins. CONCLUSION: ALG5 dysfunction adversely affects maturation and trafficking of N-glycosylated and GPI anchored protein uromodulin, leading to structural and functional changes in the kidney. Our findings confirm ALG5 as a cause of late-onset ADPKD and provide additional insight into the molecular mechanisms of ADPKD-ALG5.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kmochová, Tereza $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Benson, Katherine A $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland
- 700 1_
- $a Fennelly, Neil K $u Department of Pathology, Beaumont Hospital, Dublin, Ireland
- 700 1_
- $a Barešová, Veronika $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Kidd, Kendrah $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
- 700 1_
- $a Doyle, Brendan $u Department of Pathology, Beaumont Hospital, Dublin, Ireland
- 700 1_
- $a Dorman, Anthony $u Department of Pathology, Beaumont Hospital, Dublin, Ireland
- 700 1_
- $a Morrin, Martina M $u Department of Radiology, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland
- 700 1_
- $a Kyne, Niamh C $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland
- 700 1_
- $a Vyleťal, Petr $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Hartmannová, Hana $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Hodaňová, Kateřina $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Sovová, Jana $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Mušálková, Dita $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Vrbacká, Alena $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Přistoupilová, Anna $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Živný, Jan $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Svojšová, Klára $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Radina, Martin $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Stránecký, Viktor $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Loginov, Dmitry $u Institute of Microbiology, The Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Pompach, Petr $u Institute of Microbiology, The Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Novák, Petr $u Institute of Microbiology, The Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Vaníčková, Zdislava $u Institute of Medical Biochemistry and Laboratory Diagnostics of the General University Hospital and of The First Faculty of medicine of Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Hansíková, Hana $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Rajnochová-Bloudíčková, Silvie $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Viklický, Ondřej $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Hůlková, Helena $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Cavalleri, Gianpiero L $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland
- 700 1_
- $a Hnízda, Aleš $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Bleyer, Anthony J $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
- 700 1_
- $a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
- 700 1_
- $a Conlon, Peter J $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland $u Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
- 700 1_
- $a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
- 773 0_
- $w MED00194279 $t Kidney international reports $x 2468-0249 $g Roč. 9, č. 7 (2024), s. 2209-2226
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39081747 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241008 $b ABA008
- 991 __
- $a 20241016082024 $b ABA008
- 999 __
- $a ok $b bmc $g 2196514 $s 1230251
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 9 $c 7 $d 2209-2226 $e 20240415 $i 2468-0249 $m Kidney international reports $n Kidney Int Rep $x MED00194279
- LZP __
- $a Pubmed-20241008